BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22177242)

  • 21. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma.
    Cho HY; Lee M; Takei H; Dancer J; Ro JY; Zhai QJ
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):131-8. PubMed ID: 19521276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathologic features of endolymphatic sac tumor at cerebellopontine angle].
    Du J; Wang JM; Cui Y; Li GL
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):590-4. PubMed ID: 22177241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.
    Korshunov A; Golanov A; Timirgaz V
    J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas.
    Nordfors K; Haapasalo J; Sallinen PK; Haapasalo H; Soini Y
    Histol Histopathol; 2013 Sep; 28(9):1137-46. PubMed ID: 23423606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of histopathological ependymoma variants.
    Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
    Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunophenotype of ependymomas.
    Vege KD; Giannini C; Scheithauer BW
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):25-31. PubMed ID: 10937045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China.
    Xi S; Sai K; Hu W; Wang F; Chen Y; Wang J; Zeng J; Chen Z
    BMC Cancer; 2019 Jul; 19(1):717. PubMed ID: 31324163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase-2 (cox-2) expression and angiogenesis in intracranial ependymomas.
    Onguru O; Kurt B; Gunhan O; Soylemezoglu F
    Clin Neuropathol; 2006; 25(5):216-20. PubMed ID: 17007443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of p53 and KI-67 expression with grade and subtype of ependymoma.
    Manasa LP; Uppin MS; Sundaram C
    Indian J Pathol Microbiol; 2012; 55(3):308-13. PubMed ID: 23032822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD99 immunoreactivity in ependymoma.
    Choi YL; Chi JG; Suh YL
    Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):125-9. PubMed ID: 11396629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olig2 and CD99 are useful negative markers for the diagnosis of brain tumors.
    Ishizawa K; Komori T; Shimada S; Hirose T
    Clin Neuropathol; 2008; 27(3):118-28. PubMed ID: 18552083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma.
    Georgescu MM; Yell P; Mobley BC; Shang P; Georgescu T; Wang SH; Canoll P; Hatanpaa KJ; White CL; Raisanen JM
    Acta Neuropathol Commun; 2015 Mar; 3():11. PubMed ID: 25775275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of expression and secretion of interleukin-8 in ependymal tumor].
    Gu J; Zhang X; Li X
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):396-8. PubMed ID: 11798904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aurora B kinase expression in ependymal neoplasms.
    Gibson SE; Zeng WF; Weil RJ; Prayson RA
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):274-8. PubMed ID: 18301241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ependymal and choroid plexus tumors. Cytokeratin and GFAP expression.
    Mannoji H; Becker LE
    Cancer; 1988 Apr; 61(7):1377-85. PubMed ID: 2449946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor vessel biology in pediatric intracranial ependymoma.
    Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
    J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunohistochemical study on distribution of transthyretin in normal human brain tissue and tumors].
    Kunishio K; Shiraishi T; Mishima N; Matsumi N; Tamiya T; Honda C; Matsumoto K; Furuta T; Nishimoto A
    No To Shinkei; 1989 Mar; 41(3):245-9. PubMed ID: 2667588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A marker for primary choroid plexus neoplasms.
    Herbert J; Cavallaro T; Dwork AJ
    Am J Pathol; 1990 Jun; 136(6):1317-25. PubMed ID: 2356863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma.
    Ho DM; Hsu CY; Wong TT; Chiang H
    J Neurooncol; 2001 Aug; 54(1):77-85. PubMed ID: 11763426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.